Sunday 11 October 2026 Export all LLY data to Excel Powerpack

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,179.27 9.67 +0.83%
Market cap
$1.10T
P/E
39.6×
Fwd P/E
33.1×
Dividend yield
0.57%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
40.25 32.67 46.83 37.33

+8 more quarters

P/S ratio
13.44 11.39 14.79 11.52
P/FCF ratio
52.49 58.67 86.31 59.65
P/Operating CF
100.13 154.27 299.05 77.45
P/B ratio
31.59 26.37 36.34 28.69
Price to Tangible BV
154.68 46.50 68.31 59.48
EV/Sales
14.01 11.88 15.34 12.13
EV/EBITDA
31.24 25.58 35.32 29.38
EV/Operating CF
39.75 41.92 59.45 44.89
EV/FCF
54.75 61.21 89.46 62.85
Quick Ratio
0.68 0.72 0.78 0.73
Current Ratio
1.35 1.50 1.58 1.55
Net Debt/EBITDA
4.83 3.62 3.93 3.95
Debt/Assets
38.59% 33.77% 37.79% 35.56%
Debt/Equity
1.62 1.26 1.60 1.71
Asset Turnover
0.66 0.70 0.68 0.62
Operating CF/Net income
1.51 0.72 0.49 1.58
Capex/Depreciation
(5.49) (4.57) (4.35) (4.44)
Research and Development Expense of Revenue
16.62% 17.73% 19.70% 19.69%
Selling, General and Administrative Expense of Revenue
14.93% 14.82% 16.24% 15.57%
Intangible Assets out of Total Assets
0.19 0.12 0.11 0.11
Share Based Compensation of Revenue
0.87% 0.81% 0.71% 0.86%
Graham Net Nets
(0.04) (0.04) (0.03) (0.04)
Graham Number
159.55 148.63 123.57 110.59
Earnings Yield
2.48% 3.06% 2.14% 2.68%
Free Cash Flow Yield
1.91% 1.70% 1.16% 1.68%
Revenue per Share
25.74 22.13 21.50 19.62
Operating CF per Share
11.98 5.96 3.59 9.85
Capex per Share
(3.29) (2.60) (2.84) (2.33)
Free Cash Flow per Share
8.69 3.36 0.76 7.52
Cash per Share
10.03 5.91 8.10 11.05
Shareholders Equity per Share
37.96 34.88 29.57 26.59
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
37.96 34.88 29.57 26.59
Free Cash Flow
7,757.00 3,007.00 677.90 6,748.10
Working Capital
16,931.00 18,201.00 20,401.00 21,930.40
Capital Expenditures
(2,933.00) (2,326.00) (2,546.70) (2,087.30)
Net Current Asset Value
(43,732.00) (30,543.00) (30,312.00) (29,013.30)
EV/EBIT
33.19 27.23 38.00 31.85
Capex to Sales
0.13 0.12 0.13 0.12
Price to Operating Income
31.83 26.10 36.66 30.23
Other line items
Average Receivables
20,340.30 17,590.10 16,715.50 15,754.45
Average Payables
5,093.85 4,235.50 4,304.00 3,574.35
Average Inventory
13,903.40 11,920.00 10,666.50 9,820.10
Average Assets
121,602.80 102,982.40 95,595.50 95,271.15
Average Common Equity
26,114.05 23,522.40 20,403.50 19,085.75

Fold the line items

Columns are period end dates